SEC Comment Letter for ClearPoint Neuro, (CLPT) — Jan 27, 2021
ClearPoint Neuro, Inc.
Date: Jan. 27, 2021 · CIK: 0001285550 · Accession: 0000000000-21-001007
AI Filing Summary & Sentiment
File numbers found in text: 333-252346
Letter
United States securities and exchange commission logo January 27, 2021 Joseph Burnett Chief Executive Officer ClearPoint Neuro, Inc. 5 Musick Irvine, CA 92618 Re:ClearPoint Neuro, Inc. Registration Statement on Form S-3 Filed January 22, 2021 File No. 333-252346 Dear Mr. Burnett: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason L. Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Richard F. Mattern
Show Raw Text
United States securities and exchange commission logo
January 27, 2021
Joseph Burnett
Chief Executive Officer
ClearPoint Neuro, Inc.
5 Musick
Irvine, CA 92618
Re:ClearPoint Neuro, Inc.
Registration Statement on Form S-3
Filed January 22, 2021
File No. 333-252346
Dear Mr. Burnett:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason L. Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Richard F. Mattern